Literature DB >> 7630931

Cholinergic neurotransmission studied in vivo using positron emission tomography or single photon emission computerized tomography.

M Maziere1.   

Abstract

During the past decade, considerable efforts have been made in the development of radiopharmaceuticals for the in vivo study of the cholinergic neurotransmission using positron emission tomography or single photon emission computerized tomography. The main cholinergic radioligands, labelled with positron- or gamma-photon-emitting radionuclides, are reviewed with respect to use as in vivo markers of either acetylcholinesterase, vesicular acetylcholine transporter, brain and heart muscarinic receptors, or cholinergic nicotinic receptors. The main results obtained in the in vivo study of the physiology, pharmacology or pathology of the different steps of the cholinergic neurotransmission using single photon emission computerized tomography and positron emission tomography are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630931     DOI: 10.1016/0163-7258(95)00003-y

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  3 in total

1.  Clinical translation of neuroimaging research in mood disorders.

Authors:  Jakub Z Konarski; Roger S McIntyre; Joanna K Soczynska; Alexandra Bottas; Sidney H Kennedy
Journal:  Psychiatry (Edgmont)       Date:  2006-02

2.  Synthesis and in vitro evaluation of novel nortropane derivatives as potential radiotracers for muscarinic m(2) receptors.

Authors:  Remco J J Knol; Jan C van den Bos; Anton G M Janssen; Kora de Bruin; Berthe L F van Eck-Smit; Jan Booij
Journal:  Int J Mol Imaging       Date:  2011-06-13

Review 3.  Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT.

Authors:  Lieven D Declercq; Rik Vandenberghe; Koen Van Laere; Alfons Verbruggen; Guy Bormans
Journal:  Front Pharmacol       Date:  2016-03-31       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.